The spectrum of BRCA1 gene mutations in early onset breast cancer patients from Russia

Aim of the study. Aim of the study was to estimate the occurrence of pathogenic mutations in the BRCA1 gene in Russian breast cancer patients.

Material and methods. Complete coding sequence of the BRCA1 gene of 445 early onset  breast cancer patients (under 40 years) from Novosibirsk region (Russia) were analyzed by  targeted Next Generation Sequencing (NGS) using Ion Torrent platform. Results. Forty (9%) carriers of various pathogenic mutations were revealed. Thirty five (7,9%) patients  carried 5382insC mutation, described earlier as a founder mutation for Slavic population.  Five (1.1%) patients carried various pathogenic mutations, namely C61G, 462delCC, E143X,  4153delA, and IVS18+1G>T. Besides, 29 genetic variants with no clinical significance or with  unknown clinical significance were detected in BRCA1 gene among 445 early onset breast  cancer patients. Conclusions. Data on the frequency of genetic variations in the BRCA1 gene among early onset breast cancer patients in the Novosibirsk Region (Russia) were  obtained. Proportion of the 5382insC mutation is 87.5% of all pathogenic mutations in the BRCA1 gene found in patients.

1. Mavaddat N., Antoniou A.C., Easton D.F., Garcia-Closas M. Genetic susceptibility to breast cancer. Mol Oncol. 2010 Jun; 4(3): 174–91. doi: 10.1016/j.molonc.2010.04.011.

2. Fischer C., Kuchenbäcker K., Engel C., Zachariae S., Rhiem K., Meindl A., Rahner N., Dikow N., Plendl H., Debatin I., Grimm T., Gadzicki D., Flöttmann R., Horvath J., Schröck E., Stock F., Schäfer D., Schwaab I., Kartsonaki C., Mavaddat N., Schlegelberger B., Antoniou A.C., Schmutzler R. German Consortium for Hereditary Breast and Ovarian Cancer. Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium. J Med Genet. 2013 Jun; 50(6): 360–7. doi: 10.1136/jmedgenet-2012-101415.

3. Gayther S.A., Harrington P., Russell P., Kharkevich G., Garkavtseva R.F., Ponder B.A.J. Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia. Am J Hum Genet. 1997 May; 60(5): 1239–42.

4. Sokolenko A.P., Mitiushkina N.V., Buslov K.G., Bit-Sava E.M., Iyevleva A.G., Chekmariova E.V., Kuligina E.Sh., Ulibina Y.M., Rozanov M.E., Suspitsin E.N., Matsko D.E., Chagunava O.L., Trofimov D.Y., Devilee P., Cornelisse C., Togo A.V., Semiglazov V.F., Imyanitov E.N. High frequency of BRCA1 5382insC mutation in Russian breast cancer patients. Eur J Cancer. 2006 Jul; 42(10): 1380–84. doi: 10.1016/j.ejca.2006.01.050.

5. Sokolenko A.P., Rozanov M.E., Mitiushkina N.V., Sherina N.Y., Iyevleva A.G., Chekmariova E.V., Buslov K.G., Shilov E.S., Togo A.V., Bit- Sava E.M., Voskresenskiy D.A., Chagunava O.L., Devilee P., Cornelisse C., Semiglazov V.F., Imyanitov E.N. Founder mutations in early onset, familial and bilateral breast cancer patients from Russia. Familial Cancer. 2007; 6(3): 281–6. doi: 10.1007/s10689-007-9120-5.

6. Kwon J.S., Gutierrez-Barrera A.M., Young D., Sun C.C., Daniels M.S., Lu K.H., Arun B. Expanding the criteria for BRCA mutation testing in breast cancer survivors. J Clin Oncol. 2010 Sep; 28(27): 4214–20. doi: 10.1200/JCO.2010.28.0719.

7. Iyevleva A.G., Suspitsin E.N., Kroeze K., Gorodnova T.V., Sokolenko A.P., Buslov K.G., Voskresenskiy D.A., Togo A.V., Kovalenko S.P., Stoep N.V., Devilee P., Imyanitov E.N. Non-founder BRCA1 mutations in Russian breast cancer patients. Cancer Lett. 2010 Dec 8; 298(2): 258–63. doi: 10.1016/j.canlet.2010.07.013.

8. Anisimenko M.S., Mitrofanov D.V., Chasovnikova O.B., Voevoda M.I., Kovalenko S.P. BRCA1 gene mutations frequency estimation by allelespecific real-time PCR of pooled genomic DNA samples. Breast. 2013 Aug; 22(4): 532–6. doi: 10.1016/j.breast.2012.12.007.

9. Schmieder R., Edwards R. Quality control and preprocessing of metagenomic datasets. Bioinformatics. 2011 Mar 15; 27(6): 863–4. doi: 10.1093/bioinformatics/btr026.

10. Li H., Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009 Jul; 25(14): 1754–60. doi: 10.1093/bioinformatics/btp324.

11. Li H., Handsaker B., Wysoker A., Fennell T., Ruan J., Homer N., Marth G., Abecasis G., Durbin R.; 1000 Genome Project Data Processing Subgroup. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009 Aug 15; 25(16): 2078–9. doi: 10.1093/bioinformatics/btp352.

12. Paul G.A., Matyash N.A., Pisareva E.E., Anisimenko M.S., Kozyakov A.E., Kovalenko S.P. Detection of mutations related to hereditary cancer in relatives of breast cancer patients. Siberian Journal of Oncology. 2017; 16(4): 84–88. doi: 10.21294/1814- 4861-2017-16-4-84-88. [in Russian]

13. Ermolenko N.A., Boyarskikh U.A., Kechin A.A., Mazitova A.M., Khrapov E.A., Petrova V.D., Lazarev A.F., Kushlinskii N.E., Filipenko M.L. Massive Parallel Sequencing for Diagnostic Genetic Testing of BRCA Genes ‑ a Single Center Experience. Asian Pac J Cancer Prev. 2015; 16(17): 7935–41. doi: 10.7314/APJCP.2015.16.17.7935.

14. Bermisheva M.A., Zinnamullina G.F., Gantsev Sh.Kh., Kochanova V.A., Popov O.S., Dörk T., Khusnutdinova E.K. Frequency of 5382insC mutation of the BRCA1 gene. Vopr Onkol. 2008; 54(1): 31–3.

15. Gorodetska I., Serga S., Levkovich N., Lahuta T., Ostapchenko L., Demydov S., Anikusko N., Cheshuk V., Smolanka I., Sklyar S., Polenkov S., Boichenko O., Kozeretska I. The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from Ukraine. Hered Cancer Clin Pract. 2015 Oct; 13: 19. doi: 10.1186/s13053-015-0040-3.

16. Brozek I., Ratajska M., Piatkowska M., Kluska A., Balabas A., Dabrowska M., Nowakowska D., Niwinska A., Rachtan J., Steffen J., Limon J. Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases. Fam Cancer. 2012 Sep; 11(3): 351–4. doi: 10.1007/s10689-012-9519-5.

17. Backe J., Hofferbert S., Skawran B., Dörk T., Stuhrmann M., Karstens J.H., Untch M., Meindl A., Burgemeister R., Chang-Claude J., Weber B.H. Frequency of BRCA1 mutation 5382insC in German breast cancer patients. Gynecol Oncol. 1999 Mar; 72(3): 402–6. doi: 10.1006/gyno.1998.5270.

18. Muller D., Bonaiti-Pellié C., Abecassis J., Stoppa-Lyonnet D., Fricker J.P. BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect. Fam Cancer. 2004; 3(1): 15–20. doi: 10.1023/B:FAME.0000026819.44213.df.

19. de Juan Jiménez I., García Casado Z., Palanca Suela S., Esteban Cardeñosa E., López Guerrero J.A., Segura Huerta Á., Chirivella González I., Sánchez Heras A.B., Juan Fita M.J., Tena García I., Guillen Ponce C., Martínez de Dueñas E., Romero Noguera I., Salas Trejo D., Goicoechea Sáez M., Bolufer Gilabert P. Novel and recurrent BRCA1/ BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence. Fam Cancer. 2013 Dec; 12(4): 767–77. doi: 10.1007/s10689-013-9622-2.